SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-219907
Filing Date
2022-08-12
Accepted
2022-08-12 16:02:40
Documents
9
Effectiveness Date
2022-08-12

Document Format Files

Seq Description Document Type Size
1 S-8 d340015ds8.htm S-8 47730
2 EX-4.1 d340015dex41.htm EX-4.1 38587
3 EX-4.3 d340015dex43.htm EX-4.3 113274
4 EX-5.1 d340015dex51.htm EX-5.1 11513
5 EX-23.1 d340015dex231.htm EX-23.1 1749
6 EX-23.2 d340015dex232.htm EX-23.2 1936
7 EX-99.1 d340015dex991.htm EX-99.1 70779
8 EX-FILING FEES d340015dexfilingfees.htm EX-FILING FEES 17156
9 GRAPHIC g340015dsp1.jpg GRAPHIC 6024
  Complete submission text file 0001193125-22-219907.txt   312150
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 617.871.2101 EXT 313
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266824 | Film No.: 221159919
SIC: 2834 Pharmaceutical Preparations